In vivo testing of anti-HIV immunotoxins

Methods Mol Biol. 2001:166:277-94. doi: 10.1385/1-59259-114-0:277.
No abstract available

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • Antibodies, Monoclonal
  • Clinical Trials as Topic
  • Containment of Biohazards
  • Disease Progression
  • Drug Design
  • Drug Evaluation, Preclinical
  • Enzyme-Linked Immunosorbent Assay
  • Exotoxins / adverse effects
  • Exotoxins / therapeutic use
  • HIV Core Protein p24 / analysis
  • HIV Infections / drug therapy*
  • HIV-1 / immunology
  • HIV-1 / isolation & purification
  • HIV-1 / physiology
  • Humans
  • Immunotoxins / adverse effects
  • Immunotoxins / therapeutic use*
  • Lymphoma, T-Cell / drug therapy
  • Lymphoma, T-Cell / pathology
  • Lymphoma, T-Cell / virology
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Models, Animal
  • Radiation Chimera
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Ricin
  • Spleen / virology
  • Transplantation, Heterologous
  • Tumor Cells, Cultured / transplantation
  • Tumor Cells, Cultured / virology

Substances

  • 924-RAC
  • Anti-HIV Agents
  • Antibodies, Monoclonal
  • CD4-Pseudomonas toxin
  • Exotoxins
  • HIV Core Protein p24
  • Immunotoxins
  • Recombinant Proteins
  • Ricin